Teleflex Incorporated (NYSE:TFX) Shares Sold by New Mexico Educational Retirement Board

New Mexico Educational Retirement Board decreased its position in Teleflex Incorporated (NYSE:TFX) by 4.3% in the 4th quarter, HoldingsChannel reports. The institutional investor owned 2,200 shares of the medical technology company’s stock after selling 100 shares during the period. New Mexico Educational Retirement Board’s holdings in Teleflex were worth $392,000 at the end of the most recent reporting period.

Several other large investors have also bought and sold shares of the company. Simplify Asset Management Inc. acquired a new stake in Teleflex in the 3rd quarter valued at about $4,800,000. JPMorgan Chase & Co. lifted its stake in Teleflex by 14.3% during the third quarter. JPMorgan Chase & Co. now owns 155,158 shares of the medical technology company’s stock valued at $38,374,000 after purchasing an additional 19,466 shares during the last quarter. Sumitomo Mitsui Trust Group Inc. boosted its holdings in Teleflex by 5.2% during the fourth quarter. Sumitomo Mitsui Trust Group Inc. now owns 108,231 shares of the medical technology company’s stock worth $19,263,000 after buying an additional 5,322 shares in the last quarter. Lecap Asset Management Ltd. acquired a new position in Teleflex in the fourth quarter worth approximately $729,000. Finally, Mirae Asset Global Investments Co. Ltd. increased its holdings in shares of Teleflex by 35.1% in the fourth quarter. Mirae Asset Global Investments Co. Ltd. now owns 5,875 shares of the medical technology company’s stock valued at $1,053,000 after buying an additional 1,527 shares in the last quarter. Institutional investors own 95.62% of the company’s stock.

Teleflex Price Performance

NYSE TFX opened at $169.33 on Wednesday. The company has a 50 day simple moving average of $177.75 and a 200-day simple moving average of $208.74. Teleflex Incorporated has a 52-week low of $165.62 and a 52-week high of $253.06. The firm has a market capitalization of $7.86 billion, a price-to-earnings ratio of 33.66, a price-to-earnings-growth ratio of 1.72 and a beta of 1.16. The company has a debt-to-equity ratio of 0.37, a current ratio of 2.42 and a quick ratio of 1.39.

Wall Street Analyst Weigh In

A number of equities analysts recently issued reports on TFX shares. Mizuho decreased their target price on Teleflex from $275.00 to $250.00 and set a “neutral” rating on the stock in a report on Friday, November 1st. Truist Financial cut their price objective on Teleflex from $227.00 to $200.00 and set a “hold” rating on the stock in a report on Wednesday, December 18th. Royal Bank of Canada decreased their target price on shares of Teleflex from $275.00 to $245.00 and set an “outperform” rating for the company in a report on Friday, November 1st. Needham & Company LLC restated a “hold” rating on shares of Teleflex in a report on Monday, December 16th. Finally, StockNews.com raised shares of Teleflex from a “hold” rating to a “buy” rating in a research note on Thursday, November 28th. Three equities research analysts have rated the stock with a hold rating and five have assigned a buy rating to the company. According to data from MarketBeat.com, Teleflex presently has an average rating of “Moderate Buy” and a consensus target price of $252.50.

Teleflex Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.